These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4073 related articles for article (PubMed ID: 6752286)

  • 1. Development of a bioassay for anti tumor activity of biological response modifiers of the reticuloendothelial stimulant class: reproducibility of the bioassay.
    Proctor JW; Yamamura Y; DiLuzio NR; Mansell PW
    J Immunopharmacol; 1981-1982; 3(3-4):385-95. PubMed ID: 6752286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glucan and other adjuvants on the clearance of radiolabeled tumor cells from mouse lungs.
    Proctor JW; Stiteler RD; Yamamura Y; Mansell PW; Winters R
    Cancer Treat Rep; 1978 Nov; 62(11):1873-80. PubMed ID: 728905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant-induced selective recruitment of specifically reactive lymphocytes: a probable mechanism of adjuvant action.
    Emeson EE
    J Immunol; 1980 May; 124(5):2222-30. PubMed ID: 6245138
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between intradermal tumor suppression and tumor immunity.
    Bartlett GL; Kreider JW; Purnell DM
    J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of Corynebacterium parvum.
    Milas L; Scott MT
    Adv Cancer Res; 1978; 26():257-306. PubMed ID: 343523
    [No Abstract]   [Full Text] [Related]  

  • 7. Activated macrophages and the antitumor action of BCG.
    Alexander P
    Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
    Haskill S; Ritter F; Becker S
    J Immunol; 1980 Jul; 125(1):454-8. PubMed ID: 6247400
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitumor activity and lymphoreticular stimulation properties of fractions isolated from Corynebacterium parvum.
    Cantrell JL; Wheat RW
    Cancer Res; 1979 Sep; 39(9):3554-63. PubMed ID: 225023
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen.
    Hawrylko E; Mackaness GB
    J Natl Cancer Inst; 1973 Nov; 51(5):1677-82. PubMed ID: 4587142
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: The effect of Bacille Calmette-Guérin (BCG) and Corynebacterium parvum on the development of spontaneous mouse mammary carcinoma.
    Simpson JS; Clark AW
    Br J Surg; 1976 Feb; 63(2):152-3. PubMed ID: 766891
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models.
    Bartlett GL; Kreider JW; Purnell DM
    Cancer; 1980 Aug; 46(4):685-91. PubMed ID: 7397633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of intratumoral immunostimulants in the treatment of a transplantable rat mammary carcinoma.
    Willmott N; Austin EB; Pimm MV; Baldwin RW
    Eur J Cancer (1965); 1981 Apr; 17(4):397-405. PubMed ID: 7308253
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of nonspecific immunotherapy on the course of murine melanoma.
    Woods JE; Ritts RE
    J Surg Oncol; 1977; 9(1):15-20. PubMed ID: 839793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of immunostimulation by Corynebacterium parvum on evolution and metastatic dissemination of Lewis's tumor in mouse C57BL/6 mice].
    Pot-Deprun J; Chouroulinkov I
    C R Acad Hebd Seances Acad Sci D; 1975 Feb; 280(5):685-8. PubMed ID: 809167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy models in experimental animals.
    Ferguson RM; Schmidtke JR
    Surg Clin North Am; 1979 Apr; 59(2):349-69. PubMed ID: 87018
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunity to transplantable carcinogen-induced fibrosarcomas in B2/B2 chickens. I. Use of bacterial adjuvants in induction of immunity demonstrable in Winn tests.
    Palladino MA; Thorbecke GJ
    Cell Immunol; 1978 Jul; 38(2):336-49. PubMed ID: 354799
    [No Abstract]   [Full Text] [Related]  

  • 19. Modification of post-operative C. albicans sepsis by glucan immunostimulation.
    Browder IW; Williams DL; Kitahama A; Di Luzio NR
    Int J Immunopharmacol; 1984; 6(1):19-26. PubMed ID: 6724765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of intralesionally administered Nocardia opaca preparations in rat and mouse tumors: a comparison with BCG and Corynebacterium parvum.
    Barot-Ciorbaru R; Petit JF; Chassoux D; Salomon JC
    Int J Immunopharmacol; 1981; 3(2):115-22. PubMed ID: 7021434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 204.